XOMA (XOMAO) Stock Price, News & Analysis

Company Overview

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services. These collaborations leverage XOMA’s capabilities in protein expression, assay development, and manufacturing process design, enabling partner companies to accelerate preclinical and early clinical programs. The company’s business model combines internal drug development with fee‐based service agreements and licensing arrangements.

Founded in 1979 and headquartered in Berkeley, California, XOMA was among the early pioneers in monoclonal antibody technology. Over four decades, the company has played a role in advancing antibody therapeutics through both in‐house research and strategic partnerships. While based in the United States, XOMA’s collaborative network extends to Europe and other regions, reflecting its commitment to global drug development efforts.

Key Stats

• Today's Range: $25.00 to $25.00
• 50-Day Range: $24.96 to $25.47
• 52-Week Range: $24.86 to $26.40
• Volume: N/A
• Average Volume: 4,279 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 8.36%
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Record date for 7/14 Dividend: 7/02/2026
• Ex-Dividend for 7/14 Dividend: 7/02/2026
• Dividend Payable: 7/14/2026
• Today: 8/20/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: NASDAQ:XOMAO
• CIK: 791908
• Web: www.xoma.com
• Phone: 510-204-7200
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $7.65 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A